FRI0129 Comparative safety of biologic dmard initiation in ra: a population-based observational study of malignancy risk
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.2887
Abstract: Background Patients (pts) with RA are at increased risk for some malignancies and the use of biologic (b)DMARDs has been reported to further increase this risk.1 Abatacept (ABA), the first selective T-cell co-stimulation modulator for… read more here.
Keywords: risk; initiation; treatment; bdmard ... See more keywords